Prostate cancer: Chemoprevention with dutasterid with high risk?

被引：0
|
作者：
Werner, F
机构：
来源：
AKTUELLE UROLOGIE | 2006年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Chemoprevention of prostate cancer -: Dutasterid:: dual inhibition of the 5α reductase
    UROLOGE, 2006, 45 (02): : 283 - 283
  • [2] Can Chemoprevention Reduce the Risk of Prostate Cancer?
    Diamandis, Eleftherios P.
    CLINICAL CHEMISTRY, 2010, 56 (08) : 1214 - 1215
  • [3] Chemoprevention of prostate cancer in men at high risk: Rationale and design of the reduction by dutasteride of prostate cancer events (reduce) trial
    Andriole, G
    Bostwick, D
    Brawley, O
    Gomella, L
    Tindall, D
    Breed, S
    Somerville, M
    Rittmaster, R
    JOURNAL OF UROLOGY, 2004, 172 (04): : 1314 - 1317
  • [4] Cost-effectiveness of prostate cancer chemoprevention among high-risk men
    Zeliadt, Steven B.
    Ramsey, Scott D.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (05) : 505 - 508
  • [5] Chemoprevention of prostate cancer
    Klein, EA
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 54 (01) : 1 - 10
  • [6] Chemoprevention of Prostate Cancer
    Stephenson, Andrew J.
    Abouassaly, Robert
    Klein, Eric A.
    UROLOGIC CLINICS OF NORTH AMERICA, 2010, 37 (01) : 11 - +
  • [7] Chemoprevention in prostate cancer
    不详
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (08) : 1325 - 1325
  • [8] Chemoprevention of prostate cancer
    Schmitz-Drager, B. J.
    Lummen, G.
    Schafer, R. M.
    UROLOGE, 2007, 46 (06): : 611 - +
  • [9] Chemoprevention in prostate cancer
    Parnes, Howard L.
    Figg, William D.
    PHARMACOTHERAPY, 2006, 26 (10): : 1533 - 1533
  • [10] Chemoprevention of Prostate Cancer
    Thompson, Ian M.
    Tangen, Catherine M.
    Goodman, Phyllis J.
    Lucia, M. Scott
    Klein, Eric A.
    JOURNAL OF UROLOGY, 2009, 182 (02): : 499 - 507
12345